EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation.
Saved in:
| Title: | EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation. |
|---|---|
| Authors: | Diefenbach K; Bayer HealthCare Pharmaceuticals, Berlin, Germany., Trummer D, Ebert F, Lissy M, Koch M, Rohde B, Blode H |
| Source: | International journal of women's health [Int J Womens Health] 2013 Apr 11; Vol. 5, pp. 149-63. Date of Electronic Publication: 2013 Apr 11 (Print Publication: 2013). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101531698 Publication Model: Electronic-Print Cited Medium: Print ISSN: 1179-1411 (Print) Linking ISSN: 11791411 NLM ISO Abbreviation: Int J Womens Health Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 23610531 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Diefenbach+K%22">Diefenbach K</searchLink>; Bayer HealthCare Pharmaceuticals, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Trummer+D%22">Trummer D</searchLink><br /><searchLink fieldCode="AU" term="%22Ebert+F%22">Ebert F</searchLink><br /><searchLink fieldCode="AU" term="%22Lissy+M%22">Lissy M</searchLink><br /><searchLink fieldCode="AU" term="%22Koch+M%22">Koch M</searchLink><br /><searchLink fieldCode="AU" term="%22Rohde+B%22">Rohde B</searchLink><br /><searchLink fieldCode="AU" term="%22Blode+H%22">Blode H</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101531698%22">International journal of women's health</searchLink> [Int J Womens Health] 2013 Apr 11; Vol. 5, pp. 149-63. <i>Date of Electronic Publication: </i>2013 Apr 11 (<i>Print Publication: </i>2013). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press%22">Dove Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101531698 <i>Publication Model: </i>Electronic-Print <i>Cited Medium: </i>Print <i>ISSN: </i>1179-1411 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211791411%22">11791411 </searchLink><i>NLM ISO Abbreviation: </i>Int J Womens Health <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23610531 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2147/IJWH.S37254 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 149 Titles: – TitleFull: EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Diefenbach K – PersonEntity: Name: NameFull: Trummer D – PersonEntity: Name: NameFull: Ebert F – PersonEntity: Name: NameFull: Lissy M – PersonEntity: Name: NameFull: Koch M – PersonEntity: Name: NameFull: Rohde B – PersonEntity: Name: NameFull: Blode H IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 04 Text: 2013 Apr 11 Type: published Y: 2013 Identifiers: – Type: issn-print Value: 1179-1411 Numbering: – Type: volume Value: 5 Titles: – TitleFull: International journal of women's health Type: main |
| ResultId | 1 |
